PSNC Briefing 010/19: Reclassification of gabapentin and pregabalin as CDs (March 2019)

This briefing has been compiled to support community pharmacy teams as the reclassification of pregabalin and gabapentin as Schedule 3 Controlled Drugs (CDs) comes into force on 1st April 2019

PSNC Briefing 010/19: Reclassification of gabapentin and pregabalin as CDs (revised 15/04/2019)

If you have any queries on this PSNC Briefing or you require more information, please contact the Dispensing & Supply Team.

To browse other PSNC briefings on dispensing and supply click here.

Latest Dispensing and Supply news

CPCF Roadshow continues with London event

Following the announcement of a five-year deal on the Community Pharmacy Contractual Framework (CPCF), PSNC is holding a series of...

Shortage Notice: Tiagabine (Gabitril) 5mg, 10mg and 15mg tablets

Teva, the sole manufacturers of Tiagabine (Gabitril) 5mg, 10mg and 15mg tablets, are currently experiencing temporary supply disruptions. Teva, the...

Shortage Notice: Mianserin 10mg and 30mg tablets

Mylan, the sole manufacturers of Mianserin 10mg and 30mg tablets, are currently experiencing temporary supply disruptions. Mylan, the sole manufacturers...